Kintsugi, founded with the mission to bridge the mental health care gap, develops innovative voice biomarker software designed to detect signs of depression and anxiety from short clips of free-form speech. Their core vision is to provide accessible and non-invasive mental health diagnostics through advanced AI technology. The company offers products such as Kintsugi Voice and Kintsugi Connect, which integrate seamlessly into existing healthcare systems to enhance mental health assessments. Their market focus spans healthcare providers, insurers, and digital health platforms.
Notable figures associated with Kintsugi include its founders and a team of experts in AI and mental health. The company has garnered significant recognition, including being named one of Forbes' Top 50 AI companies to watch in 2022 and making the Fierce 15 list in 2023. These accolades underscore Kintsugi's impact on the mental health sector by providing cutting-edge tools that improve early detection and intervention for mental health conditions.